货号:A267516
同义名:
甲氯灭酸钠
/ Meclofenamate sodium; Meclofenamate (sodium salt)
Meclofenamic acid sodium是一种非甾体抗炎剂 (NSAID),具有抗炎作用,常用于研究炎症性疾病。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | COX ↓ ↑ | COX-1 ↓ ↑ | COX-2 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Piroxicam | ✔ | 98% | |||||||||||||||||
| Salicylic acid | ✔ | 98% | |||||||||||||||||
| Phenacetin | ✔ | 98% | |||||||||||||||||
| Etodolac | ✔ | 99% | |||||||||||||||||
| Flunixin meglumine | ✔ | 98% | |||||||||||||||||
| Ibuprofen L-lysine | ✔ | 98% | |||||||||||||||||
| Nabumetone | ✔ | 98% | |||||||||||||||||
| Acemetacin | ✔ | 98% | |||||||||||||||||
| Diflunisal | ✔ | 98% | |||||||||||||||||
| Pranoprofen | ✔ | 98% | |||||||||||||||||
| Ampiroxicam | ✔ | 98% | |||||||||||||||||
| Meloxicam | ✔ | 98% | |||||||||||||||||
| Sulindac | ✔ | 98% | |||||||||||||||||
| Ketoprofen | ✔ | 98% | |||||||||||||||||
| Mefenamic Acid | ✔ | 95% | |||||||||||||||||
| Bromfenac sodium | ✔ | 98% | |||||||||||||||||
| Oxaprozin | ✔ | 99% | |||||||||||||||||
| Aspirin | ✔ | 99% | |||||||||||||||||
| Nepafenac | ✔ | 98% | |||||||||||||||||
| Zaltoprofen | ✔ | 99% | |||||||||||||||||
| Salicin | ✔ | 98% | |||||||||||||||||
| Suprofen | ✔ | 99%+ | |||||||||||||||||
| Xanthohumol | ✔ | 99% | |||||||||||||||||
| Parecoxib | ✔ | 98% | |||||||||||||||||
| Tolfenamic Acid |
+++
COX-2, IC50: 0.2 μM |
98% | |||||||||||||||||
| Etoricoxib | ✔ | 99% | |||||||||||||||||
| Niflumic Acid | ✔ | 98% | |||||||||||||||||
| Valdecoxib |
++++
COX-2, IC50: 5 nM |
99+% | |||||||||||||||||
| Ibuprofen |
+
COX-1, IC50: 13 μM |
+
COX-2, IC50: 370 μM |
98% | ||||||||||||||||
| Indomethacin |
++
COX1, IC50: 0.28 μM |
+
COX-2, IC50: 14 μM |
97% | ||||||||||||||||
| Lornoxicam |
++++
COX-1, IC50: 5 nM |
++++
COX-2, IC50: 8 nM |
98% | ||||||||||||||||
| Meclofenamic acid sodium |
++++
COX-1, IC50: 40 nM |
+++
COX-2, IC50: 50 nM |
99% | ||||||||||||||||
| Asaraldehyde | ✔ | 98% | |||||||||||||||||
| Naproxen |
+
COX-1, IC50: 8.7 μM |
+
COX-2, IC50: 5.2 μM |
98% | ||||||||||||||||
| Diclofenac Sodium Salt |
+++
COX-1, IC50: 60 nM |
+++
COX-2, IC50: 200 nM |
98% | ||||||||||||||||
| NS-398 |
++
COX-2, IC50: 3.8 μM |
95% | |||||||||||||||||
| Amfenac Sodium Hydrate |
++
COX-1, IC50: 250 nM |
+++
COX-2, IC50: 150 nM |
98%+ | ||||||||||||||||
| Nimesulide |
+
COX-2, IC50: 26 μM |
98% | |||||||||||||||||
| Lumiracoxib |
++
COX-1, Ki: 3 μM |
+++
COX-2, Ki: 60 nM |
98% | ||||||||||||||||
| Rutaecarpine | ✔ | 95% | |||||||||||||||||
| Celecoxib |
++++
COX-2, IC50: 40 nM |
98% | |||||||||||||||||
| Carprofen |
++++
canine COX2, IC50: 30 nM |
98% | |||||||||||||||||
| Ketorolac |
++
COX-1 (human), IC50: 1.23 μM |
++
COX-2 (human), IC50: 3.50 μM |
98% | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Meclofenamate Sodium (MS) is an nonsteroidal anti-inflammatory drugs (NSAIDs) used to reduce pain. Addition of exogenous proteasome to MS treated cells improved cell viability[2]. Single 100- and 200-mg doses of meclofenamate sodium are as safe as, and significantly more effective than, codeine 60 mg or placebo for episiotomy pain[3]. In the majority of patients (headache and craniofacial pain), the meclofenamate sodium period scored lowest or second-lowest after the follow-up period in mean pain intensity[4]. Meclofenamate sodium in the dose administered was equally effective in relieving pain and inflammation and restoring restricted function in patients with acute gout as indometacin when used in the generally recommended dose for this indication. Meclofenamate sodium, even at these high dosage levels, was better tolerated than indometacin[5]. Similar improvement in mobility of the vertebral column and spondylitic pain could be achieved with meclofenamate sodium and indometacin in patients with ankylosing spondylitis. Meclofenamate sodium offers an effective and safe alternative to indometacin in the treatment of patients with ankylosing spondylitis[6]. |
| Concentration | Treated Time | Description | References | |
| N87 | 0 μM, 10 μM, 20 μM, 30 μM, 40 μM, 50 Μm | To evaluate the effect of Meclofenamic acid on the proliferation of N87 cells, results showed that Meclofenamic acid inhibited N87 cell growth in a dose-dependent manner. | J Exp Clin Cancer Res. 2025 Jan 7;44(1):8. | |
| HGC27 | 0 μM, 10 μM, 20 μM, 30 μM, 40 μM, 50 μM | To evaluate the effect of Meclofenamic acid on the proliferation of HGC27 cells, results showed that Meclofenamic acid inhibited HGC27 cell growth in a dose-dependent manner. | J Exp Clin Cancer Res. 2025 Jan 7;44(1):8. | |
| HeLa cells | 80 μM and 120 μM | 24 h | To investigate the effect of MA2 on the level of m6A modification in HeLa cells, the results showed that MA2 significantly increased the level of m6A modification. | Nucleic Acids Res. 2015 Jan;43(1):373-84. |
| Mouse aortic smooth muscle cells | 20 µM | Meclofenamic acid (20 µM) relaxed aortic segments precontracted with phenylephrine, and this relaxation was reversed by the Kv7 channel blocker XE991. | Br J Pharmacol. 2007 Jul;151(6):758-70. | |
| GC-1 spg cells | 40, 80, 120 μM | 48 h | MA2 significantly increased the cellular m6A level and down-regulated the expression of CDK1, CDK2, CDK6 and CdC25a, resulting in arrest of G1/S transition and decrease of cell proliferation. | J Anim Sci Biotechnol. 2019 Jul 11;10:63. |
| bladder smooth muscle cells (SMC) | 1 µM | MFA significantly reduced contraction amplitude, AUC, and baseline tone in bladder strips | Br J Pharmacol. 2013 Jul;169(6):1290-304. | |
| HPC cells | 50 mM | Treatment with MA2 significantly upregulated RNF183 protein levels, indicating that MA2 reversed the high glucose-induced downregulation of RNF183 expression by inhibiting m6A demethylase activity. | Cells. 2025 Mar 1;14(5):365. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Hemorrhage-induced thalamic pain model | Intraperitoneal injection | 1, 5, 10 mg/kg | Once daily for five days | MA significantly attenuated the Coll IV microinjection-induced TLR4 upregulation and contralateral mechanical allodynia, heat hyperalgesia, and cold hyperalgesia. | Stroke. 2021 Jul;52(7):2393-2403 |
| Fetal lambs | Fetal lambs | Intravenous or intracerebral | 0.8-10 mg/kg or 0.6-2.6 mg/kg | Not specified | Meclofenamate induced prolonged fetal breathing with a significant increase in breath amplitude, without altering blood gas values, heart rate, blood pressure, electrocortical activity, or eye movements. | J Physiol. 1985 May;362:455-66 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT02429570 | Recurrent Brain Metastases ... 展开 >> Progressive Brain Metastases 收起 << | Not Applicable | Active, not recruiting | April 2019 | United States, Florida ... 展开 >> Baptist Health South Florida Miami, Florida, United States, 33143 United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania Lehigh Valley Health Network Allentown, Pennsylvania, United States, 18103 收起 << |
| NCT02930005 | Psychotic Disorders ... 展开 >> Schizophrenia Schizoaffective Disorder Bipolar Disorder 收起 << | Phase 2 | Enrolling by invitation | November 4, 2017 | United States, Texas ... 展开 >> Harris County Psychiatric Center Houston, Texas, United States, 77021 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.14mL 0.63mL 0.31mL |
15.72mL 3.14mL 1.57mL |
31.43mL 6.29mL 3.14mL |
|
| CAS号 | 6385-02-0 |
| 分子式 | C14H10Cl2NNaO2 |
| 分子量 | 318.13 |
| SMILES Code | O=C([O-])C1=CC=CC=C1NC2=C(Cl)C=CC(C)=C2Cl.[Na+] |
| MDL No. | MFCD00077376 |
| 别名 | 甲氯灭酸钠 ;Meclofenamate sodium; Meclofenamate (sodium salt); Meclofenamic Acid; CI 583 |
| 运输 | 蓝冰 |
| InChI Key | OGPIIGMUPMPMNT-UHFFFAOYSA-M |
| Pubchem ID | 4038 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place,Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 120 mg/mL(377.2 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 100 mg/mL(314.34 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1